Doseloop Beta

Penicillamine

medication Under review

A chelating agent used to treat Wilson's disease, cystinuria, and severe rheumatoid arthritis.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Scientific evidence for penicillamine centers on its efficacy in treating Wilson's disease, cystinuria, and rheumatoid arthritis, with clinical trials and reviews demonstrating significant reductions in disease activity markers like tender joint counts, pain, and erythrocyte sedimentation rate compared to placebo. No studies were identified involving healthy human subjects, limiting insights into benefits or safety for general wellness or supplementation in non-diseased populations. Consensus emphasizes its role as a targeted therapy with notable toxicity risks, including higher withdrawal rates due to adverse reactions.

Reported Side Effects

Related health conditions

Research showing how this habit affects specific health conditions. Always consult healthcare professionals.

May Help With

Research (3 studies)

Systematic Review

Penicillamine - StatPearls

StatPearls - NCBI Bookshelf • 2023

Kusumi RK, Brooks AD

Systematic Review

Penicillamine for treating rheumatoid arthritis.

Cochrane Database of Systematic Reviews • 2000 • n=683

Suarez-Almazor ME, Burls A, Shea B

Preliminary

Studies on the metabolism of D-penicillamine and its interaction with probenecid in cystinuria and rheumatoid arthritis.

Clinical Science • 1979 • n=9

Gibbs K, Walshe JM

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 3
Researched benefits 0
Side effects noted 1